Investor Bigger Capital, LLC
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Bigger Capital, LLC . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2024-11-13 13G/A ARTHQ / Arch Therapeutics, Inc. 300,000
2024-11-12 13G/A BDRX / Biodexa Pharmaceuticals Plc - Depositary Receipt (Common Stock) 174,337,600 34,117,200
2024-11-08 13G/A ATNM / Actinium Pharmaceuticals, Inc. 1,895,202 1,555,313
2024-11-08 13G/A CLPT / ClearPoint Neuro, Inc. 1,794,948 2,045,921
2024-11-06 13G/A TANH / Tantech Holdings Ltd 500,000 50,000
2024-11-01 13G/A BFRI / Biofrontera Inc. 502,754 10,000
2024-10-30 13G/A TGCB / Tego Cyber Inc. 6,800,000
2024-05-03 13G TANH / Tantech Holdings Ltd 500,000
2024-03-15 13G BFRI / Biofrontera Inc. 502,754
2024-02-12 13G BDRX / Biodexa Pharmaceuticals Plc - Depositary Receipt (Common Stock) 174,337,600
2024-02-09 13G/A ATNM / Actinium Pharmaceuticals, Inc. 1,895,202
2024-02-06 13G/A CLPT / ClearPoint Neuro, Inc. 1,794,948
2024-02-05 13G/A INBS / Intelligent Bio Solutions Inc.
2024-02-01 13G/A US8887051006 / Tivic Health Systems Inc 0